Levetiracetam

Epilepsy

Beijing Tiantan HospitalSmall moleculePhase 4 / ApprovedActive

BBB

74/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 75/ 100
Competitive Position: 73/ 100

Competitive context

64 Active assets in the Epilepsy cohort.

Asset / Sponsor	Phase	Rating
LAMOTRIGINE Assiut University	Phase 4	BBB
Lacosamide Second Affiliated Hospital of Guangzhou Medical University	Phase 4	BBB
Carbamazepine Assistance Publique - Hôpitaux de Paris	Phase 4	BBB
Topiramate Université de Sherbrooke	Phase 4	BBB
Eslicarbazepine Acetate Bial - Portela C S.A.	Phase 4	BBB

View all 50 →

Same molecule, other indications

Levetiracetam is also rated in:

epilepsy with generalized tonic-clonic seizuresDormant

BB

Indicative · Phase 4

68 / 100

acute lymphoblastic leukemiaActive

CCC

Indicative · Phase 2

51 / 100

acute myeloid leukemiaActive

CCC

Indicative · Phase 2

48 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.